Advertisement
Screener

Avantor, Inc. (AVTR) Other Noncash Income (Expense)

1.9 / 5 stars · 29/75 Roast Me

Avantor, Inc. Other Noncash Income (Expense)

Avantor, Inc. (AVTR) reported Other Noncash Income (Expense) of $400.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.

Financial Statements › Cash Flow › Operating Activities

us-gaap:OtherNoncashIncomeExpense · last filed 2026-04-29

  • Avantor, Inc. other noncash income (expense) for the quarter ending 2026-03-31 was $400.00K.
  • Avantor, Inc. other noncash income (expense) for the quarter ending 2025-12-31 was $2.30M, a 666.67% increase year-over-year.
  • Avantor, Inc. other noncash income (expense) for the quarter ending 2025-09-30 was $1.30M, a 76.36% decline year-over-year.
  • Avantor, Inc. other noncash income (expense) for the quarter ending 2025-06-30 was -$400.00K.
  • Avantor, Inc. other noncash income (expense) for fiscal 2025 was $1.30M, a 333.33% increase from fiscal 2024.
  • Avantor, Inc. other noncash income (expense) for fiscal 2024 was $300.00K, a 57.14% decline from fiscal 2023.
  • Avantor, Inc. other noncash income (expense) for fiscal 2023 was $700.00K, a 90.00% decline from fiscal 2022.
  • Avantor, Inc. other noncash income (expense) for fiscal 2022 was $7.00M.
Period endOther Noncash Income (Expense) 3 monthOther Noncash Income (Expense) 6 monthOther Noncash Income (Expense) 6 month as first filedOther Noncash Income (Expense) 9 monthOther Noncash Income (Expense) 9 month as first filedOther Noncash Income (Expense) 12 monthOther Noncash Income (Expense) 12 month as first filed
2026-03-31$400.00K
10-Q · filed 2026-04-29
$2.70M
derived: sum of 2 quarters · filed 2026-04-29
$4.00M
derived: sum of 3 quarters · filed 2026-04-29
$3.60M
derived: sum of 4 quarters · filed 2026-04-29
2025-12-31$2.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11
$3.60M
derived: sum of 2 quarters · filed 2026-02-11
$3.20M
derived: sum of 3 quarters · filed 2026-02-11
$1.30M
10-K · filed 2026-02-11
2025-09-30$1.30M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29
$900.00K
derived: sum of 2 quarters · filed 2025-10-29
-$1.00M
10-Q · filed 2025-10-29
-$700.00K
derived: sum of 4 quarters · filed 2026-04-29
2025-06-30-$400.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01
-$2.30M
10-Q · filed 2025-08-01
-$2.00M
derived: sum of 3 quarters · filed 2026-04-29
$3.50M
derived: sum of 4 quarters · filed 2026-04-29
2025-03-31-$1.90M
10-Q · filed 2026-04-29
-$1.60M
derived: sum of 2 quarters · filed 2026-04-29
$3.90M
derived: sum of 3 quarters · filed 2026-04-29
$2.50M
derived: sum of 4 quarters · filed 2026-04-29
2024-12-31$300.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11
$5.80M
derived: sum of 2 quarters · filed 2026-02-11
$4.40M
derived: sum of 3 quarters · filed 2026-02-11
$300.00K
10-K · filed 2026-02-11
2024-09-30$5.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29
$4.10M
derived: sum of 2 quarters · filed 2025-10-29
$0.00
10-Q · filed 2025-10-29
$1.60M
derived: sum of 4 quarters · filed 2026-02-11
2024-06-30-$1.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01
-$5.50M
10-Q · filed 2025-08-01
-$3.90M
derived: sum of 3 quarters · filed 2026-02-11
-$3.50M
derived: sum of 4 quarters · filed 2026-02-11
2024-03-31-$4.10M
10-Q · filed 2025-04-25
-$2.50M
derived: sum of 2 quarters · filed 2026-02-11
-$2.10M
derived: sum of 3 quarters · filed 2026-02-11
-$1.90M
derived: sum of 4 quarters · filed 2026-02-11
2023-12-31$1.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11
$2.00M
derived: sum of 2 quarters · filed 2026-02-11
$2.20M
derived: sum of 3 quarters · filed 2026-02-11
$700.00K
10-K · filed 2026-02-11
2023-09-30$400.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-25
$600.00K
derived: sum of 2 quarters · filed 2024-10-25
-$900.00K
10-Q · filed 2024-10-25
$6.00M
derived: sum of 4 quarters · filed 2025-02-07
2023-06-30$200.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-26
-$1.30M
10-Q · filed 2024-07-26
$5.60M
derived: sum of 3 quarters · filed 2025-02-07
$10.40M
derived: sum of 4 quarters · filed 2025-02-07
2023-03-31-$1.50M
10-Q · filed 2024-04-26
$5.40M
derived: sum of 2 quarters · filed 2025-02-07
$10.20M
derived: sum of 3 quarters · filed 2025-02-07
$10.80M
derived: sum of 4 quarters · filed 2025-02-07
2022-12-31$6.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-07
$11.70M
derived: sum of 2 quarters · filed 2025-02-07
$12.30M
derived: sum of 3 quarters · filed 2025-02-07
$7.00M
10-K · filed 2025-02-07
2022-09-30$4.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27
$5.40M
derived: sum of 2 quarters · filed 2023-10-27
$100.00K
10-Q · filed 2023-10-27
$3.40M
derived: sum of 4 quarters · filed 2024-02-14
2022-06-30$600.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28
-$4.70M
10-Q · filed 2023-07-28
-$1.40M
derived: sum of 3 quarters · filed 2024-02-14
-$3.20M
derived: sum of 4 quarters · filed 2024-02-14
2022-03-31-$5.30M
10-Q · filed 2023-04-28
-$2.00M
derived: sum of 2 quarters · filed 2024-02-14
-$3.80M
derived: sum of 3 quarters · filed 2024-02-14
-$5.80M
derived: sum of 4 quarters · filed 2024-02-14
2021-12-31$3.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14
$1.50M
derived: sum of 2 quarters · filed 2024-02-14
-$500.00K
derived: sum of 3 quarters · filed 2024-02-14
-$3.00M
10-K · filed 2024-02-14
2021-09-30-$1.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28
-$3.80M
derived: sum of 2 quarters · filed 2022-10-28
-$6.30M
10-Q · filed 2022-10-28
-$8.50M
derived: sum of 4 quarters · filed 2023-02-14
2021-06-30-$2.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-29
-$4.50M
10-Q · filed 2022-07-29
-$6.70M
derived: sum of 3 quarters · filed 2023-02-14
-$7.20M
derived: sum of 4 quarters · filed 2023-02-14
2021-03-31-$2.50M
10-Q · filed 2022-04-29
-$4.70M
derived: sum of 2 quarters · filed 2023-02-14
-$5.20M
derived: sum of 3 quarters · filed 2023-02-14
-$4.70M
derived: sum of 4 quarters · filed 2023-02-14
2020-12-31-$2.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14
-$2.70M
derived: sum of 2 quarters · filed 2023-02-14
-$2.20M
derived: sum of 3 quarters · filed 2023-02-14
-$2.90M
10-K · filed 2023-02-14
2020-09-30-$500.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29
$0.00
derived: sum of 2 quarters · filed 2021-10-29
-$700.00K
10-Q · filed 2021-10-29
-$2.40M
derived: sum of 4 quarters · filed 2022-02-11
2020-06-30$500.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30
-$200.00K
10-Q · filed 2021-07-30
-$1.90M
derived: sum of 3 quarters · filed 2022-02-11
$3.70M
derived: sum of 4 quarters · filed 2022-02-11
2020-03-31-$700.00K
10-Q · filed 2021-04-28
-$2.40M
derived: sum of 2 quarters · filed 2022-02-11
$3.20M
derived: sum of 3 quarters · filed 2022-02-11
$3.70M
derived: sum of 4 quarters · filed 2022-02-11
2019-12-31-$1.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11
$3.90M
derived: sum of 2 quarters · filed 2022-02-11
$4.40M
derived: sum of 3 quarters · filed 2022-02-11
$5.30M
10-K · filed 2022-02-11
$10.00M
10-K · filed 2020-02-14
2019-09-30$5.60M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-27
$6.10M
derived: sum of 2 quarters · filed 2020-10-27
$7.00M
10-Q · filed 2020-10-27
$400.00K
10-Q · filed 2019-11-05
$33.70M
derived: sum of 4 quarters · filed 2021-02-16
2019-06-30$500.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29
$1.40M
10-Q · filed 2020-07-29
-$9.40M
10-Q · filed 2019-08-06
$28.10M
derived: sum of 3 quarters · filed 2021-02-16
$11.70M
derived: sum of 4 quarters · filed 2021-02-16
2019-03-31$900.00K
10-Q · filed 2020-04-29
$27.60M
derived: sum of 2 quarters · filed 2021-02-16
$11.20M
derived: sum of 3 quarters · filed 2021-02-16
2018-12-31$26.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16
$10.30M
derived: sum of 2 quarters · filed 2021-02-16
$9.20M
10-K · filed 2021-02-16
-$2.40M
10-K · filed 2020-02-14
2018-09-30-$16.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05
-$17.50M
10-Q · filed 2019-11-05
2018-06-30-$1.10M
10-Q · filed 2019-08-06
2017-12-31-$8.20M
10-K · filed 2020-02-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
BRUKER CORP (BRKR)United States$9.706B-128.75
REVVITY, INC. (RVTY)United States$16.814B53.44
Alamar Biosciences, Inc. (ALMR)United States$2.300B
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
908 Devices Inc. (MASS)United States$0.476B-9.53
EyePoint, Inc. (EYPT)United States$0.314B-3.96
Quanterix Corp (QTRX)United States$0.150B-1.65
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34